The Worldwide Metastatic Cancer Drug Industry is Expected to Reach $68.3 Billion by 2028
30 juin 2022 05h33 HE
|
Research and Markets
Dublin, June 30, 2022 (GLOBE NEWSWIRE) -- The "Global Metastatic Cancer Drug Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Cancer Type, Route of Administration, Drug Class,...
Immuno-Oncology Drug Development Analytical Tool 2022: 1260 Companies/Partners Who are Developing 3,896 I-O Drugs Where of 2,948 are in Active Development in Cancer Across 629 Different Targets
26 mai 2022 06h28 HE
|
Research and Markets
Dublin, May 26, 2022 (GLOBE NEWSWIRE) -- The "Immuno-Oncology Drug Development: Analytical Tool" report has been added to ResearchAndMarkets.com's offering. Immuno-Oncology Drug Development:...
Global $140+ Billion Immune Checkpoint Inhibitors Market Opportunity Analysis and Industry Forecasts to 2030
29 mars 2022 05h38 HE
|
Research and Markets
Dublin, March 29, 2022 (GLOBE NEWSWIRE) -- The "Immune Checkpoint Inhibitors Market by Type and Application: Global Opportunity Analysis and Industry Forecast, 2021-2030" report has been added to...
Global Immune Checkpoint Inhibitors $30 Billion Market Opportunity
15 mars 2022 05h53 HE
|
Research and Markets
Dublin, March 15, 2022 (GLOBE NEWSWIRE) -- The "Global Immune Checkpoint Inhibitors Biomarkers & Clinical Trials Insight 2028" drug pipelines has been added to ResearchAndMarkets.com's...
Global Checkpoint Inhibitors Market (2021 to 2030) - Featuring AstraZeneca, Roche Holding and Pfizer Among Others
07 déc. 2021 06h58 HE
|
Research and Markets
Dublin, Dec. 07, 2021 (GLOBE NEWSWIRE) -- The "Checkpoint Inhibitors Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com's offering. This...
Global Head and Neck Squamous Cell Carcinoma Drug Market Report 2021: Limited R&D in HNSCC, Resulting in a Market with Little Competition and a Stagnant Pipeline - Market Will Grow to $5.2B in 2030
08 nov. 2021 05h53 HE
|
Research and Markets
Dublin, Nov. 08, 2021 (GLOBE NEWSWIRE) -- The "Head and Neck Squamous Cell Carcinoma - Global Drug Forecast and Market Analysis to 2030" report has been added to ResearchAndMarkets.com's offering....
Global Neuroendocrine Tumors Market & Drug Forecast 2021-2030 | Most Important Unmet Needs and the Projected Impact of 5 Late-Stage Pipeline Agents Entering the Market
14 oct. 2021 07h13 HE
|
Research and Markets
Dublin, Oct. 14, 2021 (GLOBE NEWSWIRE) -- The "Neuroendocrine Tumors - Global Drug Forecast and Market Analysis to 2030" report has been added to ResearchAndMarkets.com's offering. The market of...
Worldwide Oncology Pharmaceuticals Industry to 2026 - Robust Approval of Oncology Pharmaceuticals is Driving Growth
06 oct. 2021 07h13 HE
|
Research and Markets
Dublin, Oct. 06, 2021 (GLOBE NEWSWIRE) -- The "Global Oncology Pharmaceuticals Market 2021-2026" report has been added to ResearchAndMarkets.com's offering. The global market for oncology...
AzurRx BioPharma CEO Issues Letter to Shareholders Regarding Recent Acquisition of First Wave Bio and Creation of First Wave BioPharma
14 sept. 2021 07h30 HE
|
AzurRx BioPharma, Inc.
BOCA RATON, Fla., Sept. 14, 2021 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ:AZRX), (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializing in the...
Global Checkpoint Inhibitor Refractory Cancer Market Report 2021: Marketed Therapies, Emerging Therapies, Checkpoint Inhibitors, Major Markets, Epidemiology - Forecast to 2030
17 août 2021 03h38 HE
|
Research and Markets
Dublin, Aug. 17, 2021 (GLOBE NEWSWIRE) -- The "Checkpoint Inhibitor Refractory Cancer - Market Insights, Epidemiology and Market Forecast 2030" report has been added to ResearchAndMarkets.com's...